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[3, 10, 11, 18, 19]. Neurocytomas without any connec-
tion to the ventricular system have also been described
[2, 3, 4, 7, 8, 13, 14, 27, 31, 34, 39, 43, 44]. In the litera-
ture, about 200 cases of central neurocytoma [47] and
about 60 cases of extraventricular neurocytoma are re-
ported [2, 3, 4, 7, 8, 13, 14, 27, 31, 34, 39, 43, 44]; their
incidence has been calculated to range between 0.25 and
0.5% of all intracranial tumors [47]. 
In the last few years, owing to the common clear cell
feature, these tumors were frequently misdiagnosed as
clear cell ependymomas or intraventricular oligoden-
drogliomas [47]. In 1982, Hassoun was the first to use
the term “central neurocytoma” [17]. At the present
time, the definition of “central neurocytoma” is restrict-
ed to neoplasms located within the ventricles, whereas
the terms “extraventricular neurocytoma” and “cerebral
neurocytoma” are used for central neurocytoma-like tu-
mors at the morphological, immunohistochemical, and
prognostic levels, but arising at other sites, i.e. spinal
cord, cerebellum, and different lobes of cerebral hemi-
spheres [47].
Neurocytomas, either at ventricular or extraventricu-
lar location, commonly affect young adults and have a
Summary
Neurocytoma is an unusual neuronal tumor especially
affecting young people. It commonly arises in the ven-
tricles and has a benign outcome. Herein, we report on a
rare case of extraventricular neurocytomas (right pari-
etal lobe) in a young girl admitted to hospital for a cra-
nial trauma subsequent to a seizure. The tumor, radio-
logically well-circumscribed, cystic and enhancing, was
surgically excised. The patient, who received no post
surgical treatment, is alive and well after 18 months of
follow-up. Pathological examination showed a well-dif-
ferentiated lesion composed of uniform, round cells
with perinuclear halos in a neuropil background and im-
munohistochemically positive for neuronal markers
(synaptophysin, neuron-specific enolase, neurofila-
ments). The authors emphasize the role of the morpho-
logical and immunohistochemical evaluations to recog-
nize this rare tumor.
Key words: Neurocytoma – Extraventricular – Clear
cells – Brain tumors – Synaptophysin
Introduction
Central nervous system neurocytomas are infrequent tu-
mors that occur supratentorially in the lateral ventricles




Considerations on Differential Diagnosis
Anna Maria Buccoliero1, Adele Caldarella1, Franco Ammannati2,
Pasquale Mennonna2, Antonio Taddei3, Gian Luigi Taddei1
1 Dipartimento di Patologia Umana e Oncologia, Università degli Studi di Firenze, Firenze,
2 Unità operativa di Neurochirurgia, Policlinico di Careggi, Firenze,
3 Dipartimento di Area Critica Medico-Chirurgica Sezione Chirurgia Generale e D.C.,
Firenze
Pathol. Res. Pract. 198: 627–633 (2002) 0344-0338/02/198/9-627 $15.00/0
PATHOLOGY
RESEARCH AND PRACTICE
© Urban & Fischer Verlag
ht tp://www.urbanf ischer.de/journals/prp
Address for correspondence: Gian Luigi Taddei, Diparti-
mento di Patologia Umana e Oncologia, Università degli Studi
di Firenze, viale G.B. Morgagni, 85, 50134 Firenze, Italy.
Tel.: +39-55/413756 Fax: +39-55/4379868.
E-mail: gl.taddei@unifi.it
benign clinical course [47]; nevertheless, age at clinical
presentation may range from a few days to over
65 years, and in rare cases, an unfavorable outcome was
reported [3, 9, 10, 24, 28, 32, 37, 41, 47, 48].
We report on a case of extraventricular neurocytoma
arising in the right parietal lobe of a young girl. Further-
more, comparing the morphological and immunohisto-
chemical aspects of neurocytoma with those of some ex-
traventricular and intra-axial primary clear cell tumors,
we searched for simple, rapid, and decisive elements for
the differential diagnosis on routinely formalin-fixed,
paraffin-embedded specimens.
Clinical History
The patient, a 20 year old woman, was admitted to the
Neurosurgical Service (Careggi Hospital, Florence,
Italy) for a cranial trauma subsequent to a seizure.
Computed tomography (CT) showed a parietal mass
of 2.5 cm in the right hemisphere. The lesion was locat-
ed at the cortical/sub cortical zone and appeared well-
circumscribed and cystic, with a small peripheral solid
part. Only scant edema was appreciable at the peritrigo-
nal white matter level. Homogeneous contrast enhance-
ment of the solid component was detectable following
administration of contrast medium. Magnetic resonance
confirmed the presence of a cystic and enhancing tumor
(Fig. 1).
The tumor was surgically excised. A gray-green liq-
uid was aspirated from the cystic area. The neoplastic
tissue was brown and bleeding, without macroscopical-
ly evident precise demarcation from the non pathologi-
cal brain parenchyma.
The postoperative course was uncomplicated. The pa-
tient received no postoperative treatment, and is alive
and well with no lesion persistence or recurrence 18
months after surgery.
Materials and Methods
The surgical specimen available for the histopathological eval-
uation was fixed in 10% buffered neutral formalin, entirely
sampled, and embedded in paraffin. Some sections were
stained with hematoxylin-eosin (HE) for the morphological
evaluation, whereas other sections were mounted on electro-
static slides and used for immunohistochemical study. The pri-
mary used antibodies were as follows: monoclonal antibody
against synaptophysin (SY), neuron-specific enolase (NSE),
glial fibrillary acidic protein (GFAP), and Ki-67 (Mib-1); mul-
ticlonal antibody against neurofilaments (NF); polyclonal anti-
body and S-100 protein (for clone, dilutions, and sources of
antibodies, see Table 1). The sections used for immunohisto-
chemistry were air-dried overnight at 37 °C, deparaffinized
through xylene, and dehydrated through graded alcohol. En-
dogenous peroxidase activity was blocked by immersing the
specimens in a solution of 0.5% H2O2. To recover antigenicity,
the slides were placed in a citrate buffer (10 mM, pH 6.0) and
submitted to microwave antigen enhancement (300 W for
40 min). The sections were allowed to cool down to room tem-
perature, washed with phosphate-buffered saline solution
(PBS, pH 7,4), and treated with normal horse serum (LAB VI-
SION Corporation, Fremont, California) to reduce non-specif-
ic antibody binding. After washing in PBS, the sections were
incubated with biotinylated anti mouse IgG (LAB VISION)
and then with streptavidin-biotin-peroxidase complex reagent
(LAB VISION). Following extensive washing with PBS, the
slides were treated with 3,3’-diaminobenzidine-hydrogen per-
oxide (BioGenex, San Ramon, California) as a final indicator,
and lightly counterstained with Mayer’s hematoxylin. Nega-
tive control experiments were conducted by replacing the pri-
mary antibodies with non-immune mouse serum at an equiva-
lent protein concentration. An additional section was stained
with periodic acid Shiff (PAS). 
Results
Light microscopy revealed a monotonous pattern of
round cells with large, clear cytoplasm, and round nu-
cleus with an appreciable “salt and pepper” chromatin.
Cellularity was moderate in a neuropil-like background
(Fig. 2). Acellular PAS-positive areas without neuropil-
like matrix were also recognizable (Fig. 3). The lesion
did not show necrosis, and the mitoses were exception-
al. Vascularization was rich with frequent hyalinization
of the blood vessels. Occasionally, micro-hemorrhagic
areas or psammomatous bodies were observed. Non
neoplastic reactive astrocytes were present. Homer
Wright rosettes and areas of ganglionic differentiation
were absent. 
Immunohistochemical studies led to diffuse and in-
tense staining for SY, NF, and NSE in the cytoplasm and
neuropil, disclosing the neuronal nature of the lesion
(Fig. 4; Tab. 1); S-100 protein was also positive, where-
as GFAP stained the reactive astrocytes (Fig. 4; Tab. 1).
The proliferation marker Mib-1 gave evidence of a very
low growth fraction (<2%) (Tab. 1).
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Fig. 1. Sagittal MRIs. The lesion was located in the right pari-
etal lobe at the cortical/subcortical level and appeared cystic
and contrast-enhancing with a small peripheral solid part. 
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Fig. 3. Acellular PAS positive areas
without a neuropil-like matrix were
also recognizable.
Fig. 2. Light microscopy revealed a
monotonous pattern of round cells
with large, clear cytoplasm and
round nucleus (A-C). There was
moderate cellularity in a neuropil-
like background (D). 
Discussion
Neurocytoma is a rare neoplasm that commonly occurs
at juvenile age [47]. Radiologically, neurocytoma ap-
pears as a well circumscribed, rounded or multilobated
and enhancing lesion [47]. It often shows cystic areas or
calcifications [47].
At the light microscopic level, central nervous sys-
tem neurocytoma is composed of a monomorphic pop-
ulation of round cells with uniform nuclear size and
shape and “salt and pepper” chromatin [3, 47]. A neu-
ropil-like background and zones of acellular fibrillary
matrix are typical [3, 5, 11, 14, 19, 27, 36, 47]. Neuro-
cytoma, particularly at extraventricular location, may
also show ganglionic differentiation [13, 33]. For these
cases, the definition of “ganglioneurocytoma” was in-
troduced [13, 33]. Most intriguing is the oligoden-
droglioma-like appearance with a honeycomb feature;
this appearance may cause difficulty in the diagnosis,
particularly at less common extraventricular sites. Tu-
moral cells with regular round nucleus and clear cyto-
plasm resembling oligodendrocytes are detectable in
oligodendrogliomas as well as in a great number of
central nervous system and intracranial neoplasms, i.e.
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Table 1. Clone, dilution, and source of antibodies used and immunohistochemical results
Antibody Clone Dilution Source Results (Clear cells)
SY Snp 88 Prediluted BioGenex +
(San Ramon, California)
NF DA2; FNP7; RMb020.11 1:20 Zymed Laboratories +
(San Francisco, California)
NSE MIG-N3 Prediluted BioGenex +
(San Ramon, California)
S-100 – 1:2000 Dako +
(Glostrup, Denmark)
GFAP ZCG29 Prediluted Zymed Laboratories
(San Francisco, California) –
Mib-1 Mib-1 1:80 IMMUNOTECH 2%
(Marseille, France)
Fig. 4. Immunohistochemical studies displayed diffuse and intense SY, NF, and NSE staining; GFAP-positive reactive astrocytes
are present.
neurocytoma, clear cell ependymoma, liponeurocy-
toma, dysembryoblastic neuroepithelial tumor (DNT),
pilocytic astrocytoma, pineocytoma, clear cell menin-
gioma, hemangioblastoma, pituitary adenoma, germi-
noma, medulloblastoma (particularly in its variant,
called cerebellar neuroblastoma) and metastasis [6, 15,
22, 42]. Moreover, papillary glioneuronal tumor, a dis-
tinct recently reported lesion composed of neurocytes,
ganglio and glial cells and with a pseudopapillary ar-
chitecture, may resemble an oligodendroglioma [25].
Non-tumoral lesions, i.e. demyelinating disorders, and
xanthomatous change sometimes also assume a clear
cell-like appearance [15]. The clear perinuclear halo,
generally absent in frozen sections, rapidly fixed tis-
sue, and paraffin sections obtained from frozen materi-
al [47], is commonly considered an artifact related to
delayed fixation when the cytoplasm is particularly
rich in “mucoid” ,i.e. glycosamminoglycans or lipidic
material [38]. In electron microscopic studies of clear
cell ependymomas, it was demonstrated that the pe-
ripheral parts of the cytoplasm of the tumoral clear
cells were devoid of cellular organelles showing intra-
cellular edema, and vacuolization underlining the com-
partmentation of the organelles was an important cause
of tumoral perinuclear halo [30].
The interpretation of the clear cell lesions may be dif-
ficult, and misdiagnosis and subsequent mistreatments
are possible.
Excluding the tumors with a specific and typical loca-
tion or those in which clear cell areas are often focal, i.e
pilocytic astrocytoma, liponeurocytoma, cerebral gan-
glioglioma, pituitary adenoma, germinoma, pineocy-
toma, and hemangioblastoma, and excluding the extra
axial neoplasms, i.e. meningioma, the most exact differ-
ential diagnosis ranges between extraventricular neuro-
cytoma and DNT, clear cell ependymoma, oligoden-
droglioma, and papillary glioneuronal tumor. 
Certainly, the ultrastructural study may be helpful as
far as the characterization of the histogenetic lineage
and grade of maturation of neoplasias with similar his-
tology are concerned. As early as 1982, Hausson [17]
used electron microscopy to identify neuronal differen-
tiation (microtubules, neurosecretory granules, synaps-
es) in neurocytoma, and more recently, Cenacchi [6] un-
derlined the utility of electron microscopy in defining
the lesions composed of oligodendroglial-like cells. The
contribution of the ultrastructural evaluation may be
particularly helpful when only scant material is avail-
able, such as in the case of stereotaxic biopsy, or when
the tissue has a prolonged fixation so that the immuno-
histochemical results may be altered [6].
Nevertheless, if precise clinical data and adequate tu-
moral samples are available, the correct diagnosis can
also be rendered by morphological and immunohisto-
chemical studies.
Long-standing, drug-resistant partial seizures in a
young patient, temporal localization, the presence of
mucin-rich “patterned” intracortical nodules with float-
ing neurons, and the detection of cortical dysplasia sug-
gest DNT [12, 16, 21, 26]. 
A large hemispheric enhancing cystic lesion arising
in a child, well demarcated by the adjacent brain and
with perivascular and/or true ependymal rosettes
(Homer Wright rosette are sometimes detectable in neu-
rocytoma [27]) suggest clear cell ependymoma [1, 20,
22, 23, 30, 35].
However, the tumor most commonly considered in
the differential diagnosis of neurocytoma is oligoden-
droglioma. It generally affects the frontal lobe of older
patients (young-to middle-aged adults). Although some
authors believe that oligodendroglioma and neurocy-
toma are morphologically identical, some important dif-
ferences should be considered [27, 34, 35, 46]: 
– A delicate vascular pattern with a “chicken wire” as-
pect, and the presence of minigemistocytes are common
in oligodendroglioma.
– A prominent fibrillary background is more typical of
neurocytoma.
– In the region of cortical invasion, perineuronal satelli-
tosis is more characteristic of oligodendroglioma.
Regarding papillary glioneuronal tumor, the clinical
and radiological findings are similar to cerebral neuro-
cytoma, but the characteristic pseudopapillary architec-
ture (hyalinized blood vessels surrounded by regular
cells) helps in rendering the correct diagnosis [25].
Basic data are available from the immunohistochemi-
cal characterization of the clear cells. A distinctive fea-
ture of neurocytoma is the positivity of the oligoden-
droglial–like cells for neuronal markers [3, 5, 7, 10, 11,
14, 19, 27, 29, 36, 40, 45, 46]. This case showed clear
immunopositivity for SY, NSE, and NF. In particular,
synaptophysin, a 38 Kd protein associated with the
synaptic vescicle membrane [14, 29, 40], is considered
the most useful marker in view of its specificity to the
identification of neuronal differentiation in brain tu-
mors. In contrast to oligodendroglioma, the most diffi-
cult lesion to be distinguished from neurocytoma, and in
contrast to clear cell ependymoma and DNT, diffuse and
intense synaptophysin immunoreactivity is very com-
mon in neurocytoma [3, 5, 7, 10, 11, 14, 19, 21, 23, 27,
29, 30, 36, 40, 45]. Papillary glioneurocytoma may also
be synaptophysin-positive; nevertheless, GFAP expres-
sion in the cells covering the vessels in the pseudopapil-
lary structures is typical [25].
In conclusion, we believe that if precise clinical data
are available, morphological and immunohistochemical
studies suffice to distinguish neurocytoma from more
aggressive lesions, such as ependymoma or oligoden-
droglioma, and from papillary glioneuronal tumor and
DNT (a quasi-hamartomatous glioneural process).
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